>AT5G05410.1 | DREB2A DNA binding / transcription activator/ transcription factor
MAVYDQSGDRNRTQIDTSRKRKSRSRGDGTTVAERLKRWKEYNETVEEVSTKKRKVPAKG
SKKGCMKGKGGPENSRCSFRGVRQRIWGKWVAEIREPNRGSRLWLGTFPTAQEAASAYDE
AAKAMYGPLARLNFPRSDASEVTSTSSQSEVCTVETPGCVHVKTEDPDCESKPFSGGVEP
MYCLENGAEEMKRGVKADKHWLSEFEHNYWSDILKEKEKQKEQGIVETCQQQQQDSLSVA
DYGWPNDVDQSHLDSSDMFDVDELLRDLNGDDVFAGLNQDRYPGNSVANGSYRPESQQSG
FDPLQSLNYGIPPFQLEGKDGNGFFDDLSYLDLEN*
>AT5G05410.1 | DREB2A DNA binding / transcription activator/ transcription factor
MAVYDQSGDRNRTQIDTSRKRKSRSRGDGTTVAERLKRWKEYNETVEEVSTKKRKVPAKG
SKKGCMKGKGGPENSRCSFRGVRQRIWGKWVAEIREPNRGSRLWLGTFPTAQEAASAYDE
AAKAMYGPLARLNFPRSDASEVTSTSSQSEVCTVETPGCVHVKTEDPDCESKPFSGGVEP
MYCLENGAEEMKRGVKADKHWLSEFEHNYWSDILKEKEKQKEQGIVETCQQQQQDSLSVA
DYGWPNDVDQSHLDSSDMFDVDELLRDLNGDDVFAGLNQDRYPGNSVANGSYRPESQQSG
FDPLQSLNYGIPPFQLEGKDGNGFFDDLSYLDLEN*
>AT5G05410.2 | DREB2A DNA binding / transcription activator/ transcription factor
MAVYDQSGDRNRTQIDTSRKRKSRSRGDGTTVAERLKRWKEYNETVEEVSTKKRKVPAKG
SKKGCMKGKGGPENSRCSFRGVRQRIWGKWVAEIREPNRGSRLWLGTFPTAQEAASAYDE
AAKAMYGPLARLNFPRSDASEVTSTSSQSEVCTVETPGCVHVKTEDPDCESKPFSGGVEP
MYCLENGAEEMKRGVKADKHWLSEFEHNYWSDILKEKEKQKEQGIVETCQQQQQDSLSVA
DYGLNQDRYPGNSVANGSYRPESQQSGFDPLQSLNYGIPPFQLEGKDGNGFFDDLSYLDL
EN*
>AT5G05410.2 | DREB2A DNA binding / transcription activator/ transcription factor
MAVYDQSGDRNRTQIDTSRKRKSRSRGDGTTVAERLKRWKEYNETVEEVSTKKRKVPAKG
SKKGCMKGKGGPENSRCSFRGVRQRIWGKWVAEIREPNRGSRLWLGTFPTAQEAASAYDE
AAKAMYGPLARLNFPRSDASEVTSTSSQSEVCTVETPGCVHVKTEDPDCESKPFSGGVEP
MYCLENGAEEMKRGVKADKHWLSEFEHNYWSDILKEKEKQKEQGIVETCQQQQQDSLSVA
DYGLNQDRYPGNSVANGSYRPESQQSGFDPLQSLNYGIPPFQLEGKDGNGFFDDLSYLDL
EN*
>AT1G68560.1 | XYL1 (ALPHA-XYLOSIDASE 1) alpha-N-arabinofuranosidase/ hydrolase hydrolyzing O-glycosyl compounds / xylan 14-beta-xylosidase
MASSSSSLAFSLSLLLALILCFSPTQSYKTIGKGYRLVSIEESPDGGFIGYLQVKQKNKI
YGSDITTLRLFVKHETDSRLRVHITDAKQQRWEVPYNLLPREQPPQVGKVIGKSRKSPIT
VQEISGSELIFSYTTDPFTFAVKRRSNHETLFNTTSSLVFKDQYLEISTSLPKEASLYGL
GENSQANGIKLVPNEPYTLYTEDVSAINLNTDLYGSHPMYMDLRNVGGKAYAHAVLLLNS
NGMDVFYRGDSLTYKVIGGVFDFYFIAGPSPLNVVDQYTQLIGRPAPMPYWSLGFHQCRW
GYHNLSVVEDVVDNYKKAKIPLDVIWNDDDHMDGHKDFTLNPVAYPRAKLLAFLDKIHKI
GMKYIVINDPGIGVNASYGTFQRAMAADVFIKYEGKPFLAQVWPGPVYFPDFLNPKTVSW
WGDEIKRFHDLVPIDGLWIDMNEVSNFCSGLCTIPEGKQCPSGEGPGWVCCLDCKNITKT
RWDDPPYKINATGVVAPVGFKTIATSATHYNGVREYDAHSIYGFSETIATHKGLLNVQGK
RPFILSRSTFVGSGQYAAHWTGDNQGTWQSLQVSISTMLNFGIFGVPMVGSDICGFYPQP
TEELCNRWIEVGAFYPFSRDHANYYSPRQELYQWDTVADSARNALGMRYKILPFLYTLNY
EAHMTGAPIARPLFFSFPEYTECYGNSRQFLLGSSFMISPVLEQGKTEVEALFPPGSWYH
MFDMTQAVVSKNGKRVTLPAPLNFVNVHLYQNTILPTQQGGLISKDARTTPFSLVIAFPA
GASEGYATGKLYLDEDELPEMKLGNGQSTYVDFYASVGNGTMKMWSQVKEGKFALSKGWV
IEKVSVLGLRGAGQVSEIQINGSPMTKKIEVSSKEHTYVIGLEDEEENKSVMVEVRGLEM
LVGKDFNMSWKMGIN*
>AT5G11720.1 | alpha-glucosidase 1 (AGLU1)
MSSLHWFPNIFIVVVVFFSLRSSQVVLEEEESTVVGYGYVVRSVGVDSNRQVLTAKLDLI
KPSSVYAPDIKSLNLHVSLETSERLRIRITDSSQQRWEIPETVIPRAGNHSPRRFSTEED
GGNSPENNFLADPSSDLVFTLHNTTPFGFSVSRRSSGDILFDTSPDSSDSNTYFIFKDQF
LQLSSALPENRSNLYGIGEHTKRSFRLIPGETMTLWNADIGSENPDVNLYGSHPFYMDVR
GSKGNEEAGTTHGVLLLNSNGMDVKYEGHRITYNVIGGVIDLYVFAGPSPEMVMNQYTEL
IGRPAPMPYWSFGFHQCRYGYKNVSDLEYVVDGYAKAGIPLEVMWTDIDYMDGYKDFTLD
PVNFPEDKMQSFVDTLHKNGQKYVLILDPGIGVDSSYGTYNRGMEADVFIKRNGEPYLGE
VWPGKVYFPDFLNPAAATFWSNEIKMFQEILPLDGLWIDMNELSNFITSPLSSGSSLDDP
PYKINNSGDKRPINNKTVPATSIHFGNISEYDAHNLYGLLEAKATHQAVVDITGKRPFIL
SRSTFVSSGKYTAHWTGDNAAKWEDLAYSIPGILNFGLFGIPMVGADICGFSHDTTEELC
RRWIQLGAFYPFARDHSSLGTARQELYLWDSVASSARKVLGLRMRLLPHLYTLMYEAHVS
GNPIARPLFFSFPQDTKTYEIDSQFLIGKSIMVSPALKQGAVAVDAYFPAGNWFDLFNYS
FAVGGDSGKHVRLDTPADHVNVHVREGSIVAMQGEALTTRDARKTPYQLLVVASRLENIS
GELFLDDGENLRMGAGGGNRDWTLVKFRCYVTGKSVVLRSEVVNPEYASKMKWSIGKVTF
VGFENVENVKTYEVRTSERLRSPRISLIKTVSDNDDPRFLSVEVSKLSLLVGKKFEMRLR
LT*
>AT3G45940.1 | alpha-xylosidase putative
MASCLSLLVAIILCFSSLQCSNAIGKGYRLISMEKSPDDGSFIGYLQVKQSNKIYGSDIT
ILRLFINYRTDHRLRVHITDAKKQRWEVPYNLLRREQPPNVIGKSRKSPVTVQEISGPEL
ILIFTVDPFSFAVRRRSNGETIFNTSSSDESFGEMVFKDQYLEISTSLPKDASLYGFGEN
SQANGIKLVPNEPYTLFTEDVSAFNLNTDLYGSHPVYMDLRNVSGKAYAHSVLLLNSHGM
DVFYRGDSLTYKVIGGVFDFYFFAGPSPLNVVDQYTSLIGRPAPMPYWSLGFHQCRWGYR
NVSVVKDVVDNYQKAKIPLDVIWNDADYMDGYKDFTLDLVNFPHAKLLSFLDRIHKMGMK
YVVIKDPGIGVNASYGVYQRGMASDVFIKYEGKPFLAQVWPGPVYFPDFLNPKTVSWWGD
EIRRFHELVPIDGLWIDMNEINATGHKASLGFKTIPTSAYHYNGVREYDAHSIYGFSEAI
ATHKALLAVQGKRPFILSRSTFVGSGQYAAHWTGDNQGTWQSLQVSISTMLNFGIFGVPM
VGSDICGFFPPTPEELCNRWIEVGAFYPFSRDHADYYAPRKELYQWGTVAESARNALGMR
YKLLPFLYTLNYEAHMSGAPIARPLFFSFPEFTECYGLSKQFLLGSSLMISPVLEQGKTQ
VEALFPPGSWYHMFDMTQVVVSKNGRLFTLPAPFNVVNVHLYQNAILPMQQVVAFPAGAS
EGYASGKLFLDDDELPEMKLGNGKSTYIDFYASVGNESVKIWSQVKEGQFALSQGLVIEK
VIVLGLKGTWKVSEILLNGSSISNETKTIEVSSKEQMYVVGSEDEGESKSFMVELKGLEM
LVGKDFNISWKMASTNVLSMAGNEVIAR*
>AT5G65560.1 | pentatricopeptide (PPR) repeat-containing protein
MIRRIQPRCNSGLTGSVSAFEVLKKKFSTDVTVPSPVTRRQFCSVSPLLRNLPEEESDSM
SVPHRLLSILSKPNWHKSPSLKSMVSAISPSHVSSLFSLDLDPKTALNFSHWISQNPRYK
HSVYSYASLLTLLINNGYVGVVFKIRLLMIKSCDSVGDALYVLDLCRKMNKDERFELKYK
LIIGCYNTLLNSLARFGLVDEMKQVYMEMLEDKVCPNIYTYNKMVNGYCKLGNVEEANQY
VSKIVEAGLDPDFFTYTSLIMGYCQRKDLDSAFKVFNEMPLKGCRRNEVAYTHLIHGLCV
ARRIDEAMDLFVKMKDDECFPTVRTYTVLIKSLCGSERKSEALNLVKEMEETGIKPNIHT
YTVLIDSLCSQCKFEKARELLGQMLEKGLMPNVITYNALINGYCKRGMIEDAVDVVELME
SRKLSPNTRTYNELIKGYCKSNVHKAMGVLNKMLERKVLPDVVTYNSLIDGQCRSGNFDS
AYRLLSLMNDRGLVPDQWTYTSMIDSLCKSKRVEEACDLFDSLEQKGVNPNVVMYTALID
GYCKAGKVDEAHLMLEKMLSKNCLPNSLTFNALIHGLCADGKLKEATLLEEKMVKIGLQP
TVSTDTILIHRLLKDGDFDHAYSRFQQMLSSGTKPDAHTYTTFIQTYCREGRLLDAEDMM
AKMRENGVSPDLFTYSSLIKGYGDLGQTNFAFDVLKRMRDTGCEPSQHTFLSLIKHLLEM
KYGKQKGSEPELCAMSNMMEFDTVVELLEKMVEHSVTPNAKSYEKLILGICEVGNLRVAE
KVFDHMQRNEGISPSELVFNALLSCCCKLKKHNEAAKVVDDMICVGHLPQLESCKVLICG
LYKKGEKERGTSVFQNLLQCGYYEDELAWKIIIDGVGKQGLVEAFYELFNVMEKNGCKFS
SQTYSLLIEGPPDST*